Anthea Pharma Profile
Key Indicators
- Authorised Capital ₹ 350.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 300.00 Cr
as on 24-10-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 550.48 Cr
as on 24-10-2024
- Revenue 296.18%
(FY 2023)
- Profit 18.13%
(FY 2023)
- Ebitda -62.72%
(FY 2023)
- Net Worth 50.54%
(FY 2023)
- Total Assets 134.45%
(FY 2023)
About Anthea Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 350.00 Cr and a paid-up capital of Rs 300.00 Cr.
The company currently has active open charges totaling ₹550.48 Cr.
The Key Managerial Personnel (KMP) at Anthea Pharma Private Limited India is Suchita Dugar as COMPANY SECRETARY. Pavan Gorukanti and Abhinav Gorukanti serve as directors at the Company.
- CIN/LLPIN
U24304TG2019PTC136590
- Company No.
136590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anthea Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suchita Dugar  | Company Secretary | 01-Aug-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhinav Gorukanti | Director | 05-Nov-2019 | Current |
| Pavan Gorukanti | Director | 31-Aug-2020 | Current |
Financial Performance and Corporate Structure Insights of Anthea Pharma.
Anthea Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 296.18% increase. The company also saw a substantial improvement in profitability, with a 18.13% increase in profit. The company's net worth Soared by an impressive increase of 50.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anthea Pharma?
In 2023, Anthea Pharma had a promoter holding of 49.00% and a public holding of 51.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yashoda Healthcare Services Private LimitedActive 31 years 4 monthsPavan Gorukanti and Abhinav Gorukanti are mutual person
- Summit Real Estates Pvt LtdActive 18 years 11 months
Pavan Gorukanti and Abhinav Gorukanti are mutual person
- Yashoda Avenues Private LimitedActive 10 years 8 months
Pavan Gorukanti and Abhinav Gorukanti are mutual person
- Aakasam Infrastructure Development Private LimitedActive 12 years 5 months
Pavan Gorukanti and Abhinav Gorukanti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Feb 2023 | ₹4.76 M | Open |
Canara Bank Creation Date: 31 May 2022 | ₹550.00 Cr | Open |
How Many Employees Work at Anthea Pharma?
Anthea Pharma has a workforce of 332 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anthea Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anthea Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
